Dr Bond and Dr Lau stated that hormone therapy may be appropriate when a woman is younger than 60 years or within 10 years of menopause. “In addition, she should have moderate to severe symptoms that ...

Precardioversion monitoring with smartphone photoplethysmography reduces same-day cardioversion cancellations for patients with AF.

Researchers compared the safety and efficacy profiles of oral P2Y12 inhibitors among patients receiving percutaneous coronary intervention.

Cannabis beverages are increasingly turning up in stores next to other beverages, and doctors warn the easy access is putting kids at risk.

Social prescribing, which connects people with support activities, may help adolescents waiting for specialist mental health services.

Blood-based biomarkers (BBM) for Alzheimer disease (AD) improve accuracy of diagnosis, according to a study presented at the annual Alzheimer’s Association In ...

The AHA released a scientific statement on tailored exercise training for patients with high-risk cardiovascular conditions.

The American Heart Association issued a scientific statement on deprescribing for patients with cardiovascular disease and polypharmacy.

Kalshi and AppliedXL launch a pilot prediction market for late-stage clinical trial outcomes and FDA decisions using objective public data sources.

Finerenone plus empagliflozin combination therapy reduces systolic blood pressure in patients with T2D and chronic kidney disease.

A cohort study indicates prepregnancy BMI and race, ethnicity interact to influence the prevalence and risk for preeclampsia, eclampsia.